{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:40Z","timestamp":1793913940402,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpainsymman.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:44:55Z","timestamp":1789195495000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketamine Analgesia for Refractory Mucositis Pain (KARM): A Prospective, Double-Blind, Randomized, Phase 2 Study of Ketamine for Oral and Pharyngeal Mucositis Pain"],"prefix":"10.1016","author":[{"given":"Khunthong","family":"Peechatanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim Edward","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Min","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-1895","authenticated-orcid":false,"given":"Naomi T","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-0380","authenticated-orcid":false,"given":"Andrew A","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-3430","authenticated-orcid":false,"given":"Peter","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","article-title":"Oral mucositis: the hidden side of cancer therapy","volume":"39","author":"Pulito","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0002","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.jpainsymman.2026.09.003_bib0003","doi-asserted-by":"crossref","first-page":"v139","DOI":"10.1093\/annonc\/mdv202","article-title":"Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"26","author":"Peterson","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0004","first-page":"57","article-title":"The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies","volume":"72","author":"Elad","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0006","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/0022034514540174","article-title":"Review of preclinical studies on treatment of mucositis and associated pain","volume":"93","author":"Viet","year":"2014","journal-title":"J Dent Res"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0007","first-page":"4023","article-title":"The pathogenesis of mucositis: updated perspectives and emerging targets","volume":"27","author":"Bowen","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0008","article-title":"Ketamine as an adjuvant to opioids for cancer pain","volume":"6","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0009","article-title":"Ketamine for pain management","volume":"3","author":"Bell","year":"2018","journal-title":"Pain Rep"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SPC.0000000000000262","article-title":"Ketamine for cancer pain: what is the evidence?","volume":"11","author":"Jonkman","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0011","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/pan.14324","article-title":"Intravenous opioids for chemotherapy-induced severe mucositis pain in children: systematic review and single-center case series of management with patient- or nurse-controlled analgesia (PCA\/NCA)","volume":"32","author":"Walker","year":"2022","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0013","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1460-9592.2010.03358.x","article-title":"The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA\/NCA) increases analgesic efficacy in children with mucositis pain","volume":"20","author":"James","year":"2010","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0014","first-page":"3539","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients","volume":"29","author":"Miranda-Silva","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1460-9592.2010.03515.x","article-title":"Pain management in 100 episodes of severe mucositis in children","volume":"21","author":"White","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0016","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/082585971002600306","article-title":"The effectiveness and adverse effects profile of \"burst\" ketamine in refractory cancer pain: the VCOG PM 1-00 study","volume":"26","author":"Jackson","year":"2010","journal-title":"J Palliat Care"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0017","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0885-3924(01)00340-2","article-title":"\"Burst\" ketamine for refractory cancer pain: an open-label audit of 39 patients","volume":"22","author":"Jackson","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0018","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1200\/JCO.2012.42.1081","article-title":"Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain","volume":"30","author":"Hardy","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cden.2013.12.005","article-title":"Chemotherapy or radiation-induced oral mucositis","volume":"58","author":"Lalla","year":"2014","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1200\/JCO.2012.47.1235","article-title":"Ketamine and cancer pain: the reports of my death have been greatly exaggerated","volume":"31","author":"Jackson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0021","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0885-3924(03)00162-3","article-title":"Clinically important changes in acute pain outcome measures: a validation study","volume":"25","author":"Farrar","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2026.09.003_bib0024","article-title":"Pain assessment","volume":"15","author":"Haefeli","year":"2006","journal-title":"Eur Spine J"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0025","series-title":"Common terminology criteria for adverse events (CTCAE) version 5.0.","year":"2017"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0026","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.apmr.2004.11.049","article-title":"Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients","volume":"86","author":"Crary","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0029","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1124\/dmd.113.051631","article-title":"The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitro","volume":"41","author":"Li","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/bcp.12614","article-title":"CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects","volume":"80","author":"Li","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1515\/sjpain-2020-0067","article-title":"Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study","volume":"21","author":"Schaller","year":"2021","journal-title":"Scand J Pain"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3959(91)90109-B","article-title":"Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain","volume":"46","author":"Mackie","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1507097","article-title":"Perioperative low-dose ketamine for postoperative pain management in spine surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"Zhou","year":"2022","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0035","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/j.pain.0000000000002283","article-title":"Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: initiative on methods, measurement, and pain assessment in Clinical trials recommendations","volume":"162","author":"Gewandter","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2026.09.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29693","article-title":"Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients","volume":"69","author":"Anghelescu","year":"2022","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600970X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600970X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:44:26Z","timestamp":1793911466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539242600970X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S088539242600970X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.09.003","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine Analgesia for Refractory Mucositis Pain (KARM): A Prospective, Double-Blind, Randomized, Phase 2 Study of Ketamine for Oral and Pharyngeal Mucositis Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}